Patents Examined by Dianne Rees
-
Patent number: 5821055Abstract: Methods and compositions are provided for the production of a polypeptide which is immunologically cross-reactive with a naturally-occurring major outer membrane protein (MOMP) of Chlamydia trachomatis. A DNA construct including a replication system recognized by E. coli, and an MOMP gene under the transcriptional control of a .beta.-galactosidase promoter and terminator is provided.Recombinant phage .lambda.gt11/L2/33 was deposited at the American Type Culture Collection, 12301 Parklawn Drive, Rockville, Md. 20852, on Jan. 10, 1985 and granted accession no. 40157. L2 B9-F DNA was deposited at the American Type Culture Collection on Dec. 31, 1985, and granted accession No. 40217.Type: GrantFiled: June 6, 1995Date of Patent: October 13, 1998Assignees: Washington Research Foundation, Chiron CorporationInventors: Nina Agabian, Richard Stephens, Cho-Chou Kuo, Guy Mullenbach
-
Patent number: 5817782Abstract: The present invention provides a unique eukaryotic gene, called LAG1, which controls the longevity of eukaryotic cells. According to the present invention, overexpression of LAG1 in older cells has a rejuvenating effect which not only increases cellular life span but also reproductive capacity and cellular tolerance to stress factors such as starvation and low pH. Moreover, the present invention identifies two domains in LAG1 one having a life span limiting function and the other a life span extending function. Hence, according to the present invention, the longevity and tolerance to stress of cells is increased when provided with the wild type polypeptide or mutant LAG1 polypeptides which, for example, lack the "life span limiting domain.Type: GrantFiled: November 8, 1994Date of Patent: October 6, 1998Assignee: Research Corporation Technologies, Inc.Inventor: S. Michal Jazwinski
-
Patent number: 5814492Abstract: A method for reducing background caused by target-independent generation of amplification products, typically the products of a ligase chain reaction or a polymerase chain reaction, involves chemically "masking" or blocking the amplification probes or primers so that they cannot be extended or ligated until the occurrence of a triggering event which can be delayed until the amplification reaction is begun. The probe masks take the form of complementary blocking oligonucleotides that are incapable of serving as template themselves and inhibit random tailing of the probe/primers. The blocking oligo masks are denatured from the probes during amplification and preferably are effectively eliminated from competing for probes in the amplification reaction.Type: GrantFiled: August 13, 1997Date of Patent: September 29, 1998Assignee: Abbott LaboratoriesInventors: John J. Carrino, Thomas D. Brainard
-
Patent number: 5814442Abstract: The invention relates generally to the quantitation of virus and viral nucleic acid. The invention relates to methods for quantitating an amount of virus present in a sample, comprising introducing into the sample a composition comprising a genetically tagged viral nucleic acid, isolating said wild type and said tagged nucleic acid, and quantitating said wild type and said tagged nucleic acid. The invention also relates to genetically tagged retroviral nucleic acid comprising a tag sequence, including insertions and deletions.Type: GrantFiled: June 10, 1994Date of Patent: September 29, 1998Assignee: Georgetown UniversityInventors: Venkatachala Natarajan, Norman P. Salzman
-
Patent number: 5811231Abstract: This invention provides methods and diagnostic kits for identifying and characterizing toxic compounds. These methods and diagnostic kits measure transcription or translation levels from genes linked to native eukaryotic stress promoters, especially those of mammals. The kits and methods of this invention utilize at least one stress promoter from each of the following groups: redox stress, DNA stress, protein stress and energy/ionic stress. The invention also provides methods and diagnostic kits for identifying and characterizing compounds that are toxic to specific organs, such as skin and the eye, as well as for each of the individual stresses indicated above. The methods and diagnostic kits of this invention yield information concerning the action of a compound on a subcellular level. This information may be utilized to design antitoxins to compounds found to be toxic and in active drug design.Type: GrantFiled: July 21, 1995Date of Patent: September 22, 1998Assignees: Pres. and Fellows of Harvard College, Xenometrix, Inc.Inventors: Spencer B. Farr, Marque D. Todd
-
Patent number: 5811236Abstract: Electrochemiluminiscent moieties having the formula?Re(P).sub.m (L.sup.1).sub.n (L.sup.2).sub.o (L.sup.3).sub.p (L.sup.4).sub.q (L.sup.5).sub.r (L.sup.6).sub.s !.sub.t (B).sub.uwhereinP is a polydentate ligand of Re;L.sup.1, L.sup.2, L.sup.3, L.sup.4, L.sup.5 and L.sup.6 are ligands of Re, each of which may be the same as or different from each other ligand;B is a substance which is a ligand of Re or is conjugated to one or more of P, L.sup.1, L.sup.2, L.sup.3, L.sup.4, L.sup.5 or L.sup.6 ;m is an integer equal to or greater than 1;each of n, o, p, q, r and s is zero or an integer;t is an integer equal to or greater than 1; andu is an integer equal to or greater than 1;P, L.sup.1, L.sup.2, L.sup.3, L.sup.4, L.sup.5, L.sup.6 and B being of such composition and number that the chemical moiety can be induced to emit electromagnetic radiation and the total number of bonds to Re provided by the ligands of Re being equal to the coordination of Reare disclosed.Type: GrantFiled: June 6, 1995Date of Patent: September 22, 1998Assignee: IGEN International, Inc.Inventors: Richard J. Massey, Michael J. Powell, Walter J. Dressick, Jonathan K. Leland, Janel K. Hino, Mohindar S. Poonian, Leopoldo Della Ciana
-
Patent number: 5807679Abstract: The present invention is a technique which allows one to determine rapidly the nucleic acid sequence of large fragments of nucleic acids such as the inserts obtained from YACs, BACs and Pls. This method uses an array of random primers matched pairwise in all combinations to amplify portions of the fragments to be sequenced. Some of these PCR reactions result in the formation of single bands of amplified DNA which are called islands. These islands are randomly scattered along the fragment of nucleic acid. These individual islands are sequenced, but this leaves major gaps in the complete sequence of DNA. A second round of PCR is performed in which the ends of the islands are used to design primers pointing away from the islands, these primers being matched pairwise in all combinations. This round of PCR again results in some of the reactions forming single bands of amplified nucleic acid. These bands connect the islands determined earlier.Type: GrantFiled: July 7, 1995Date of Patent: September 15, 1998Assignee: Myriad Genetics, Inc.Inventor: Alexander Kamb
-
Patent number: 5807527Abstract: A solid medium for storage of DNA, including blood DNA, comprising a solid matrix having a compound or composition which protects against degradation of DNA incorporated into or absorbed on the matrix. Methods for storage of DNA using this solid medium, and for recovery of DNA or in situ use of DNA are also disclosed.Type: GrantFiled: September 21, 1995Date of Patent: September 15, 1998Assignee: Flinders Technologies Pty. Ltd.Inventor: Leigh Alexander Burgoyne
-
Patent number: 5804376Abstract: The present invention provides nucleotide and amino acid sequences that identify and encode a novel pancreas-derived serpin (PDS) expressed in human pancreas. The present invention also provides for antisense molecules to the nucleotide sequences which encode PDS, expression vectors for the production of purified PDS, antibodies capable of binding specifically to PDS, hybridization probes or oligonucleotides for the detection of PDS-encoding nucleotide sequences, genetically engineered host cells for the expression of PDS, diagnostic tests based on PDS-encoding nucleic acid molecules and a pharmaceutical composition containing PDS capable of binding specifically to a serine protease.Type: GrantFiled: May 2, 1995Date of Patent: September 8, 1998Assignee: Incyte Pharmaceuticals, Inc.Inventors: Scott Michael Braxton, Craig G. Wilde, Dinh Diep
-
Patent number: 5800994Abstract: A new method has been developed for conducting a gene probe assay. The preferred technique involves (1) using a gene amplification technique (e.g., PCR) to multiply the gene sequence of interest and (2) using a hybridization--ligation detection methodology, wherein the sequences of probes hybridized to the target sequence allow for separation and detection (e.g., probes might contain a combination of magnetic particles and acridinium esters) to determine if a specific sequence is present.Type: GrantFiled: July 24, 1996Date of Patent: September 1, 1998Assignee: Chiron Diagnostics CorporationInventors: Richard A. Martinelli, John C. Arruda
-
Patent number: 5800766Abstract: The present invention relates to a method of compacting a plurality of flat, stacked, non-woven cotton and cotton blend articles from a normal size to a greatly reduced size to form a package of such articles that saves exterior packaging, shipping, handling and warehouse costs. The pressure and time dwell are selected to compact the stacked articles to the extent necessary to cause the desired size reduction, but not sufficient to either damage the articles or compact them to the degree that a liquid or other means is required to recover them from their compacted to their original size.Type: GrantFiled: March 4, 1997Date of Patent: September 1, 1998Inventor: Wayne M. Merry
-
Patent number: 5798448Abstract: The present invention provides nucleic acids encoding AL-1 protein, as well as AL-1 protein produced by recombinant DNA methods. Such AL-1 protein is useful in preparing antibodies and in diagnosing and treating various neuronal disorders.Type: GrantFiled: May 15, 1995Date of Patent: August 25, 1998Assignee: Genentech, Inc.Inventors: Ingrid W. Caras, John W. Winslow
-
Patent number: 5798209Abstract: Methods of treating diseases or conditions, characterized by elevated serum lipoprotein levels, by providing elevated levels of a VLDL receptor in an animal, e.g., a human are set forth. Such receptors aid in removal of circulating VLDL and related lipoproteins, and thus decrease the risk of developing coronary diseases or conditions or decrease the severity of such diseases or conditions. Clones of human and mouse VLDL receptor which can be used in the invention are also provided. Vectors for the expression of VLDL receptors, stably transfected and transformed cells and transgenic animals are also provided.Type: GrantFiled: May 26, 1995Date of Patent: August 25, 1998Assignee: Baylor College of MedicineInventor: Lawrence C. B. Chan
-
Patent number: 5795717Abstract: A synthetic oligonucleotide which is complementary to a nucleotide sequence of a gene selected from the group consisting of the Shiga toxin gene of Shigella species, the ipaH gene of Shigella species and EIEC, the invE gene of Shigella species and EIEC, the araC gene of Salmonella species, the Verocytotoxin-1 gene of EHEC or VTEC, the Verocytotoxin-2 gene of EHEC or VTEC, the toxic shock syndrome toxin-1 gene of Staphylococcus aureus, the ctx gene of Vibrio cholerae, and the enterotoxin gene of Clostridium perfringens; a method for detecting a bacterial strain by amplifying a region of the above gene by PCR using the above oligonucleotides as primers and detecting the amplified region; and a kit for the detection of the bacterial strain.Type: GrantFiled: October 25, 1994Date of Patent: August 18, 1998Assignee: Shimadzu CorporationInventors: Tomoko Nakayama, Jun Tada, Shigeru Fukushima, Tetsuo Ohashi
-
Patent number: 5795716Abstract: A computer system for analyzing nucleic acid sequences is provided. The computer system is used to perform multiple methods for determining unknown bases by analyzing the fluorescence intensities of hybridized nucleic acid probes. The results of individual experiments are improved by processing nucleic acid sequences together. Comparative analysis of multiple experiments is also provided by displaying reference sequences in one area and sample sequences in another area on a display device.Type: GrantFiled: October 21, 1994Date of Patent: August 18, 1998Inventor: Mark S. Chee
-
Patent number: 5792664Abstract: Methods of producing biopolymer ladders and their use to obtain structural information about the biopolymer. The ladders are produced by setting up catalytic cleavage and terminating reactions at the end of biopolymer molecules. The terminating reactions terminate cleavage of a percentage of the biopolymer molecules at each round of cleavage.Type: GrantFiled: June 7, 1995Date of Patent: August 11, 1998Assignees: The Rockefeller University, Scripps Research Institute, Ciphergen Biosystems, Inc.Inventors: Brian T. Chait, Rong Wang, Stephen B. H. Kent, Steven M. Clark
-
Patent number: 5789242Abstract: The invention concerns a method for determining the toxicity of water-soluble substances or of substances which can be mixed with water and thus obtaining quantitative information concerning the toxic effect of said substances. The invention helps to reduce the number of tests, necessary hitherto, performed on mammals. According to the method, at least two measurements determine the variation in mobility and/or size of test organisms in an aqueous medium, under the influence of at least one toxic substance. A device for carrying out the method comprises an image-detection unit which detects the object and sequentially records images of this object in at least one plane at predetermined time intervals. Arranged downstream of the image-detection unit is an evaluation arrangement with a computer and display devices which statistically evaluate the mobility and/or size of the organisms in relation to the existing toxicity.Type: GrantFiled: September 18, 1996Date of Patent: August 4, 1998Assignee: Schweizerische Eidgenossenshaft Vertreten Durch Das AC-Laboratorium Spiez Der Gruppe RustungInventors: Rudolf Portmann, Mathias Leumann, Stefan Thommen
-
Patent number: 5786141Abstract: Biomolecule analysis using anodic oxidation of aqueous sodium 9, 10-diphenylanthracene-2-sulfonate (DPAS) and 1- and 2-thianthrenecarboxylic acid (1-THCOOH and 2-THCOOH) in the presence of tri-n-propylamine (TPrA) as a coreactant in aqueous solution produces electrogenerated chemiluminescence (ECL). In addition, the cathodic reduction of DPAS in the presence of peroxydisulfate (S.sub.2 O.sub.8.sup.2-) as a coreactant also produces ECL in an acetonitrile (MeCN)-water solution (1:1 by volume). The oxidation of chlorpromazine (CPZ) produces an ECL emission in the absence of an added coreactant following an unprecedented "self-annihilation" mechanism.Type: GrantFiled: February 9, 1995Date of Patent: July 28, 1998Inventors: Allen J. Bard, Thomas Richards, Jonathan K. Leland
-
Patent number: 5786138Abstract: Attaching certain ligands to antisense probes will hyperstabilize sense-antisense duplexes. Such a hyperstabilized duplex is resistant to melting of the strands from one another, to unwinding of the strands, and to the action of nucleases. Applications include antiretroviral action, anti-reverse-transcriptase action, antiviral action, antiparasitical action, antibacterial action, antifungal action, anticancer action, anti-oncogene action, and other applications where it is desired to inhibit gene expression at the genomic or messenger RNA level. The preferred ligands are certain minor-groove-binding agents, exemplified by CC-1065 and synthetic CC-1065 analogs.Type: GrantFiled: August 11, 1994Date of Patent: July 28, 1998Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical CollegeInventor: David H. Swenson
-
Patent number: 5786144Abstract: The present invention provides a method and compositions for species identification from small samples of fish tissue. The method includes the use of the polymerase chain reaction (PCR) to amplify regions of the mitochondrial genome from total cellular DNA with species-specific primers and subsequent analysis of the PCR products. The method provides an accurate and rapid determination of the species of origin for a single egg of processed caviar. Compositions for PCR primers specific for 27 species of sturgeon are provided.Type: GrantFiled: May 13, 1996Date of Patent: July 28, 1998Assignee: American Museum of Natural HistoryInventors: Rob DeSalle, Vadim J. Birstein